NIH recently updated its annual categorical information with fiscal year (FY) 2023 actual spending data and estimates for FY 2024 and 2025. Available on the Research, Condition, and Disease Categorization (RCDC) page, you will find the annual support level for various research, condition, and disease categories. The data are based on grants, contracts, intramural projects, and other funding mechanisms used across NIH.
There were 215 public categories when RCDC information began being reported for fiscal year 2008. Today, there are a total of 324 categories. The following new categories were added in FY 2023:
- Biodefense and Medical Countermeasures*
- Building Research Capacity at Institutions with Limited NIH Funding*
- Fentanyl Misuse and Addiction
- Harm Reduction for Substance Misuse
- Health Disparities and Racial or Ethnic Minority Health Research*
- Health Disparities Research*
- Menopause
- Natural Products
- Primary Health Care
- Racial and Ethnic Minority Health Research*
- Recovery Support Services
- Workforce Diversity and Outreach*
Note, asterisks reflect new categories created when shifting from manual to automatic coding methodologies to improve accuracy and transparency. The new categories replaced Biodefense, Health Disparities, and Minority Health.
There were also two existing categories that were renamed including:
- PASC including Long COVID is now called Post-Acute Sequelae of SARS-CoV-2 infection (PASC) Including Long COVID
- Vascular Cognitive Impairment/Dementia (VCID) is now called Vascular Contributions to Cognitive Impairment/Dementia (VCID)
For more background on RCDC, please see this NIH Open Mike blog and the RCDC process here.
0 Comments